Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Koos P. J. van Dam
224  Ergebnisse:
Personensuche X
?
1

Suppressed IgG4 class switching in dupilumab‐ and TNF inhib..:

Valk, Anika M. ; Keijser, Jim B. D. ; van Dam, Koos P. J....
Allergy.  , 2024
Link: https://doi.org/10.1111/..
 
?
2

T cell activation markers CD38 and HLA-DR indicative of non..:

Verstegen, Niels J M ; Hagen, Ruth R ; Kreher, Christine...
Journal of Neurology, Neurosurgery & Psychiatry.  , 2024
Link: https://doi.org/10.1136/..
 
?
3

Longitudinal rheumatoid factor autoantibody responses after..:

Keijzer, Sofie ; Oskam, Nienke ; Ooijevaar-de Heer, Pleuni...
Frontiers in Immunology.  15 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
4

Disease activity in patients with immune-mediated inflammat..:

van Dam, Koos P.J. ; Wieske, Luuk ; Stalman, Eileen W....
Journal of Autoimmunity.  135 (2023)  - p. 102984 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Primary SARS-CoV-2 infection in patients with immune-mediat..:

van Dam, Koos P. J. ; Volkers, Adriaan G. ; Wieske, Luuk...
BMC Infectious Diseases.  23 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
6

Humoral responses after second and third SARS-CoV-2 vaccina..:

Wieske, Luuk ; van Dam, Koos P J ; Steenhuis, Maurice...
The Lancet Rheumatology.  4 (2022)  5 - p. e338-e350 , 2022
Link: https://doi.org/10.1016/..
 
?
7

Longitudinal SARS-CoV-2 humoral response in MS patients wit..:

van Dam, Koos P. J. ; Hogenboom, Laura ; Stalman, Eileen W....
Frontiers in Neurology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
8

Risk factors associated with short-term adverse events afte..:

Wieske, Luuk ; Kummer, Laura Y. L. ; van Dam, Koos P. J....
BMC Medicine.  20 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
9

Ocrelizumab Concentration Is a Good Predictor of SARS‐CoV‐2..:

van Kempen, Zoé L. E. ; Hogenboom, Laura ; Toorop, Alyssa A....
Annals of Neurology.  93 (2022)  1 - p. 103-108 , 2022
Link: https://doi.org/10.1002/..
 
?
10

DataSheet_1_Longitudinal rheumatoid factor autoantibody res..:

Sofie Keijzer ; Nienke Oskam ; Pleuni Ooijevaar-de Heer...
doi:10.3389/fimmu.2024.1314507.s001.  , 2024
Link: https://doi.org/10.3389/..
 
?
11

DataSheet_1_Longitudinal rheumatoid factor autoantibody res..:

Sofie Keijzer ; Nienke Oskam ; Pleuni Ooijevaar-de Heer...
doi:10.3389/fimmu.2024.1314507.s001.  , 2024
Link: https://doi.org/10.3389/..
 
?
12

Persistence of seroconversion at 6 months following primary..:

Wieske, Luuk ; Stalman, Eileen W ; van Dam, P J Koos...
https://research.rug.nl/en/publications/2645b3bc-4c39-4f9a-87da-1fc0bccd69d1.  , 2023
Link: https://hdl.handle.net/1..
 
?
13

Primary SARS-CoV-2 infection in patients with immune-mediat..:

van Dam, Koos P. J ; Volkers, Adriaan G ; Wieske, Luuk...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189216/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
14

Disease activity in patients with immune-mediated inflammat..:

van Dam, Koos P.J ; Wieske, Luuk ; Stalman, Eileen W...
https://research.rug.nl/en/publications/5ec1e85a-ec6c-4b98-89d2-4641ea56a756.  , 2023
Link: https://hdl.handle.net/1..
 
?
15

Primary SARS-CoV-2 infection in patients with immune-mediat..:

van Dam, Koos P J ; Volkers, Adriaan G ; Wieske, Luuk...
https://research.rug.nl/en/publications/02f1078a-9d22-4978-894d-da2bdf428b09.  , 2023
Link: https://hdl.handle.net/1..
 
1-15